Menu Close

Trending

Pfizer vaults into sickle cell market as GBT deal confirmed
ODM standard for CRF design
Bayer bags swift OK for Nubeqa in metastatic prostate cancer
Digital health app linked to better outcomes in heart failure
AZ gets FDA nod for Enhertu in first HER2-low cancer

COVID vaccine

covid-19 vaccine

R&D/ Views & Analysis/ Views and analysis

CanSinoBIO developed a highly effective COVID vaccine with an inhalant version

, , , , 0 Comment

Pierre A. Morgon, PharmD, LL.M, MBA, managing director at CanSino Biologics Europe, tells us about Convidecia, a single

X
CanSinoBIO developed a highly effective COVID vaccine with an inhalant version
https://pharmaphorum.com/r-d/cansinobio-developed-highly-effective-covid-vaccine-with-inhalant-version/
2022

Market Access/ Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis

Nine for 2022: International issues that are compelling, new or changed in 2022

, , , , 0 Comment

The year 2020 ended on a note of hope, with the 8th December vaccination of 91-year-old Margaret Keenan,

X
Nine for 2022: International issues that are compelling, new or changed in 2022
https://pharmaphorum.com/r-d/international-issues-compelling-new-changed-2022/

Login

CONTINUE TO SITE >
X
Close in 10 seconds